Showing results (131-140 of 152) with videos related to
Sort By:
Pageof 16
British Journal of Pharmacology|June 1, 1986
The sulphoxide moiety of substituted benzimidazoles is essential for inhibition of parietal cell K+/H+-ATPaseW Beil, M Eltze, K Heintze, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 3, 1998
Effects of PGE2 and of different synthetic PGE derivatives on the glycosylation of pig gastric mucinsM L Enss, H K Heim, S Wagner, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1991
Investigations on the metabolic pathways of cyclosporine: II. Elucidation of the metabolic pathways in vitro by human liver microsomesU Christians, S Strohmeyer, R Kownatzki, et al.Artificial Organs|April 1, 1995
A novel bioreactor design for in vitro reconstruction of in vivo liver characteristicsA Bader, E Knop, K Böker, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000
Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatinW Jacobsen, B Kuhn, A Soldner, et al.Clinical Chemistry|September 1, 1996
Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometryF Streit, U Christians, H M Schiebel, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 1999
Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liverW Jacobsen, G Kirchner, K Hallensleben, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|November 25, 2000
Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressantsU Christians, W Jacobsen, N Serkova, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1991
Investigations on the metabolic pathways of cyclosporine: I. Excretion of cyclosporine and its metabolites in human bile--isolation of 12 new cyclosporine metabolitesU Christians, S Strohmeyer, R Kownatzki, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
Contribution of cyclosporin metabolites to immunosuppression in liver-transplanted patients with severe graft dysfunctionH J Schlitt, U Christians, J Bleck, et al.Pageof 16